Natco Pharma Ltd has announced an interim dividend of ₹2 per equity share of face value ₹2 each, translating to 100% payout, for the financial year 2025-26.
The company’s Board has fixed Tuesday, 19th August 2025, as the record date for determining the eligibility of shareholders entitled to receive the interim dividend. Only those shareholders whose names appear in the Company’s register or in the records of the depositories as of this date will be eligible.
The payment process for the interim dividend will commence from Tuesday, 26th August 2025. Eligible shareholders can expect the dividend to be credited to their bank accounts or dispatched through dividend warrants within the stipulated time frame as per statutory guidelines.
On August 14, 2025, Natco Pharma share price (NSE: NATCOPHARM) opened at ₹902.00 and closed at ₹873.70, down by 3.38%. The stock price touched its day’s low at ₹870.00.
Also Read: Best Pharma Stocks in August!
Over the past financial year, Natco Pharma has maintained a track record of rewarding its shareholders through dividend payouts. Notably, it declared interim dividends of ₹1.25 (February 2024), ₹3.00 (August 2024), ₹1.50 (November 2024), and ₹1.50 (February 2025), followed by ₹2.00 (August 2025).
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Aug 18, 2025, 8:44 AM IST
Nikitha Devi
Nikitha is a content creator with 7+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates